Lack of Evidence of Endogenous Avian Leukosis Virus and Endogenous Avian Retrovirus Transmission to Measles, Mumps, and Rubella Vaccine Recipients
2001

No Evidence of Avian Retrovirus Transmission in MMR Vaccine Recipients

Sample size: 206 publication Evidence: high

Author Information

Author(s): Althaf I. Hussain, Vedapuri Shanmugam, William M. Switzer, Shirley X. Tsang, Aly Fadly, Donald Thea, Rita Helfand, William J. Bellini, Thomas M. Folks, Walid Heneine

Primary Institution: Centers for Disease Control and Prevention

Hypothesis

Is there evidence of endogenous avian leukosis virus (ALV) and endogenous avian retrovirus (EAV) transmission to recipients of measles, mumps, and rubella (MMR) vaccines?

Conclusion

The study found no evidence of infection with either ALV or EAV in MMR vaccine recipients.

Supporting Evidence

  • All serum samples from 206 MMR vaccine recipients were negative for antibodies to endogenous ALV.
  • Peripheral blood lymphocyte samples from 100 vaccinees tested negative for both ALV and EAV proviral sequences.
  • Matching serum samples tested negative for ALV and EAV RNA, indicating no evidence of viremia.

Takeaway

The researchers checked if kids who got the MMR vaccine caught any viruses from the vaccine, and they found none.

Methodology

Serologic and molecular methods were used to analyze specimens from 206 MMR vaccine recipients for evidence of ALV and EAV infection.

Limitations

The study did not test for antibodies and plasma viremia in all samples, which may limit the understanding of transmission risks.

Participant Demographics

The study population consisted of 206 children, with 113 from a perinatal HIV transmission study and 93 from a study of antibody responses to MMR vaccination.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication